Should you buy M&M, OIL, BHEL, Zomato, Crompton Greaves, other stocks today? Here is what brokerages recommend
As Dalal Street enters the February 15 session, brokerages have several stocks on their radar.
As Dalal Street enters the February 15 session, brokerages have several stocks on their radar. Here's what Goldman Sachs, Jefferies, Macquarie, JPMorgan, Citi, Morgan Stanley, CLSA, HSBC and Nomura make of stocks such as Mahindra & Mahindra (M&M), Oil India Ltd (OIL), Bharat Heavy Electricals Ltd (BHEL), Zomato and Crompton Greaves Consumer Electricals Ltd:
M&M share price target:
Four brokerages, CLSA, Citi, HSBC and Nomura have maintained 'buy' ratings on the Mahindra & Mahindra (M&M) stock with targets of Rs 2,074, Rs 1,890, Rs 1,900 and Rs 2,143, respectively.
Jefferies has maintained a 'hold' call on the stock with a target of Rs 1,615
Both JPMorgan and Morgan Stanley have maintained their 'overweight' ratings on M&M shares with targets of Rs 1,880 and Rs 1,952, respectively.
Macquarie has maintained an 'outperform' rating on M&M with a target of Rs 1,801.
ABFRL share price target:
Morgan Stanley has maintained an 'underweight' rating on the Aditya Birla Fashion and Retail (ABFRL) stock with a target of Rs 176.
Crompton share price target:
Morgan Stanley has maintained an 'equal-weight' rating on the Crompton Greaves Consumer Electricals Ltd stock with a target of Rs 281.
Macquarie has maintained an 'outperform' rating on the Crompton shares with a target of Rs 329.
Nomura has maintained a 'neutral' rating on Crompton Greaves shares with a target of Rs 321.
Muthoot Finance share price target:
CLSA has maintained a 'reduce' rating on the Muthoot Finance stock with a target of Rs 1,440.
Morgan Stanley has maintained an 'underweight' rating on Muthoot Finance shares with a target of Rs 1,165.
Zomato share price target:
CLSA has maintained a 'buy' call on the Zomato stock with a target of Rs 227.
Gland Pharma share price target:
Both Jefferies and Goldman Sachs have maintained 'buy' ratings on the Gland Pharma stock with targets of Rs 2,400 and Rs 2,125, respectively.
On the other hand, Citi has maintained a 'sell' call on the stock with a target of Rs 1,310.
Nomura has maintained a 'neutral' rating on the Gland Pharma shares with a target of Rs 1,570.
BHEL share price target:
Morgan Stanley has an 'equal-weight' rating on the Bharat Heavy Electricals Ltd (BHEL) stock with a target of Rs 220.
Prestige Estates share price target:
CLSA has a 'buy' call on the Prestige Estates Projects stock with a target of Rs 1,440.
Citi has maintained a 'buy' call on Prestige Estates shares with a target of Rs 1,281.
Morgan Stanley has maintained an 'overweight' rating on Prestige Estates with a target of Rs 1,300, while Jefferies has maintained an 'underperform' rating on the stock with a target of Rs 985.
OIL share price target:
CLSA has maintained a 'buy' call on the Oil India Ltd (OIL) stock with a target of Rs 575
Morgan Stanley has maintained an 'overweight' rating on OIL shares with a target of Rs 487.
Catch the latest stock market updates here. For all other news related to business, politics, tech and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations
Small SIP, Big Impact: Rs 1,111 monthly SIP for 40 years, Rs 11,111 for 20 years or Rs 22,222 for 10 years, which do you think works best?
Power of Compounding: How long it will take to build Rs 5 crore corpus with Rs 5,000, Rs 10,000 and Rs 15,000 monthly investments?
10:08 AM IST